Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-10
DOI
10.1038/s41467-017-02688-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Semi-automated cancer genome analysis using high-performance computing
- (2017) Giuliano Crispatzu et al. HUMAN MUTATION
- Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
- (2017) E I Andersson et al. LEUKEMIA
- DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification
- (2017) Lixin Chen et al. SCIENCE
- EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma
- (2016) Junli Yan et al. BLOOD
- Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma
- (2016) R. L. Boddicker et al. BLOOD
- Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas
- (2016) D. Vallois et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
- (2016) Cristina López et al. BRITISH JOURNAL OF HAEMATOLOGY
- Repair Pathway Choices and Consequences at the Double-Strand Break
- (2016) Raphael Ceccaldi et al. TRENDS IN CELL BIOLOGY
- Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors
- (2016) Kenta Yamamoto et al. eLife
- Not All DDRs Are Created Equal: Non-Canonical DNA Damage Responses
- (2015) Rebecca C. Burgess et al. CELL
- Genetic characterization of T-PLL reveals two major biologic subgroups andJAK3mutations as prognostic marker
- (2015) Anna Stengel et al. GENES CHROMOSOMES & CANCER
- Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia
- (2015) Itziar Salaverria et al. GENES CHROMOSOMES & CANCER
- Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden
- (2015) Christian Prinz et al. Molecular Cancer
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia
- (2015) Zainul S. Hasanali et al. Science Translational Medicine
- Argonaute 2: A Novel Rising Star in Cancer Research
- (2015) ZhenLong Ye et al. Journal of Cancer
- Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
- (2014) M. J. Kiel et al. BLOOD
- Bendamustine is effective in T-Cell prolymphocytic leukaemia
- (2014) Charles Herbaux et al. BRITISH JOURNAL OF HAEMATOLOGY
- ATM regulates cell fate choice upon p53 activation by modulating mitochondrial turnover and ROS levels
- (2014) Kelly D Sullivan et al. CELL CYCLE
- Ago2 facilitates Rad51 recruitment and DNA double-strand break repair by homologous recombination
- (2014) Min Gao et al. CELL RESEARCH
- Recurrent mutation ofJAK3in T-cell prolymphocytic leukemia
- (2014) Anke K. Bergmann et al. GENES CHROMOSOMES & CANCER
- Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
- (2014) Teresa Palomero et al. NATURE GENETICS
- Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions
- (2013) M. Ambrose et al. BLOOD
- Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia
- (2013) Georg Hopfinger et al. CANCER
- Mechanisms of Programmed DNA Lesions and Genomic Instability in the Immune System
- (2013) Frederick W. Alt et al. CELL
- Models for mature T-cell lymphomas—A critical appraisal of experimental systems and their contribution to current T-cell tumorigenic concepts
- (2013) Kathrin Warner et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia
- (2013) D Bellanger et al. LEUKEMIA
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Argonaute proteins: functional insights and emerging roles
- (2013) Gunter Meister NATURE REVIEWS GENETICS
- Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation
- (2013) Maura Costello et al. NUCLEIC ACIDS RESEARCH
- T-Cell Receptor Signaling in Peripheral T-Cell Lymphoma – A Review of Patterns of Alterations in a Central Growth Regulatory Pathway
- (2013) Kathrin Warner et al. Current Hematologic Malignancy Reports
- The ATM signaling network in development and disease
- (2013) Travis H. Stracker et al. Frontiers in Genetics
- How I treat prolymphocytic leukemia
- (2012) C. Dearden BLOOD
- MuSiC: Identifying mutational significance in cancer genomes
- (2012) N. D. Dees et al. GENOME RESEARCH
- Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice
- (2012) Kenta Yamamoto et al. JOURNAL OF CELL BIOLOGY
- Loss of ATM kinase activity leads to embryonic lethality in mice
- (2012) Jeremy A. Daniel et al. JOURNAL OF CELL BIOLOGY
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Argonaute proteins couple chromatin silencing to alternative splicing
- (2012) Maya Ameyar-Zazoua et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route
- (2011) C. E. Dearden et al. BLOOD
- Tcl1 interacts with Atm and enhances NF- B activation in hematologic malignancies
- (2011) E. Gaudio et al. BLOOD
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
- (2011) Philip J. Stephens et al. CELL
- High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia
- (2009) M. Herling et al. BLOOD
- Emerging Paradigms in Cancer Genetics: Some Important Findings from High-Density Single Nucleotide Polymorphism Array Studies
- (2009) M. D. Bacolod et al. CANCER RESEARCH
- Resistance of mature T cells to oncogene transformation
- (2008) S. Newrzela et al. BLOOD
- Acetylation Is Indispensable for p53 Activation
- (2008) Yi Tang et al. CELL
- Complementary functions of ATM and H2AX in development and suppression of genomic instability
- (2008) S. Zha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More